NEW UPDATE ALERT.....................
McGraw-Hill INTERNAL UPDATES FORM
| Date: |
April 29, 2018 |
| Site: |
accesspharmacy.com |
| Title of Book and Edition: |
Pharmacotherapy: A Pathophysiologic Approach, 10th Edition |
| Author: |
DiPiro JT, et al, eds. |
| Chapter number/chapter title: |
Chapter 56: Epilepsy |
| Location of Update in the chapter: |
Treatment, Pharmacologic Therapy |
Content Update
April 29, 2018
Risk of Hemophagocytic Lymphohistiocytosis with Lamotrigine Use: Lamotrigine is an antiepileptic medication used for management of epilepsy and mood disorders such as bipolar disorder. The U.S. Food and Drug Administration issued a new warning regarding the risk for hemophagocytic lymphohistiocytosis (HLH), which is a rare immune system reaction.
Create a Free MyAccess Profile
AccessMedicine Network is the place to keep up on new releases for the Access products, get short form didactic content, read up on practice impacting highlights, and watch video featuring authors of your favorite books in medicine. Create a MyAccess profile and follow our contributors to stay informed via email updates.